[HTML][HTML] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised …
Background This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
[PDF][PDF] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled …
G Elke, F Bloos, DC Wilson, FM Brunkhorst, J Briegel… - 2018 - core.ac.uk
Background: This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
[PDF][PDF] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled …
G Elke, F Bloos, DC Wilson, FM Brunkhorst… - 2018 - publications.goettingen-research …
Background: This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled trial.
G Elke, F Bloos, DC Wilson, FM Brunkhorst, J Briegel… - 2018 - cabidigitallibrary.org
Background: This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
[PDF][PDF] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled …
G Elke, F Bloos, DC Wilson, FM Brunkhorst, J Briegel… - 2018 - academia.edu
Background: This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
[PDF][PDF] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled …
G Elke, F Bloos, DC Wilson, FM Brunkhorst… - 2018 - opus.bibliothek.uni-augsburg.de
Background: This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
[引用][C] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled …
G Elke, F Bloos, DC Wilson, FM Brunkhorst, J Briegel… - Critical Care, 2018 - cir.nii.ac.jp
The use of mid-regional proadrenomedullin to identify disease severity and treatment response
to sepsis - a secondary analysis of a large randomised controlled trial | CiNii Research CiNii …
to sepsis - a secondary analysis of a large randomised controlled trial | CiNii Research CiNii …
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised controlled trial
G Elke, F Bloos, DC Wilson, FM Brunkhorst, J Briegel… - Critical Care, 2018 - go.gale.com
Background This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
[HTML][HTML] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised …
G Elke, F Bloos, DC Wilson, FM Brunkhorst… - Critical …, 2018 - ccforum.biomedcentral.com
This study assessed the ability of mid-regional proadrenomedullin (MR-proADM) in
comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive protein) and …
comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive protein) and …
[HTML][HTML] The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis-a secondary analysis of a large randomised …
G Elke, F Bloos, DC Wilson, FM Brunkhorst, J Briegel… - Critical Care, 2018 - ncbi.nlm.nih.gov
Background This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …